EIF2A and fatty liver disease: Pre-clinical studies have shown that carbon monoxide upregulates sestrin-2 through the PERK-eIF2α-ATF4 signaling pathway and alleviates dietary methionine/choline deficiency induced hepatic steatosis (23).